ALK-negative ALCL arising in a breast peri-implant capsule and associated seroma. a Low-power examination of the initial implant capsulectomy specimen reveals an apparent benign chronic inflammatory infiltrate in a background of dense fibrosis (H&E, ×40); however, atypical, but focally necrotic, large cells with hyperchromatic, irregular nuclei, and abundant eosinophilic cytoplasm are visible on high magnification (inset, H&E, ×400). b Large malignant-appearing cells with high nuclear-to-cytoplasmic ratios, prominent nucleoli, vacuolated cytoplasm, and mitotic figures are present in a cytospin of the seroma aspirate (Wright-Giemsa stain, ×1,000). c The second implant capsulectomy contains fibrosis, chronic inflammation, and more conspicuous clusters of large, atypical cells adjacent to the seroma cavity (H&E, ×100). d Viable clusters of large infiltrating cells have pleomorphic nuclei and prominent nucleoli with occasional “hallmark cells” present (H&E, ×400). e The implant capsule contains focal deposits of refringent, nonpolarizable material consistent with silicone adjacent to partially viable clusters of large atypical cells (H&E, ×400). f–h Immunohistochemical staining demonstrates the neoplastic cells to be positive for CD4 (f) and CD30 (g), but negative for ALK-1 (h; ×400). i T-cell receptor PCR identified a clonal rearrangement with Vγ10 primers (174.5 bp, blue tracing), as well as an indeterminate peak with Vγ1-8 primers (218.6 bp, green tracing), consistent with the presence of a clonal T-cell population